SNT 25.7% 4.4¢ syntara limited

response letter, page-4

  1. 11,092 Posts.
    lightbulb Created with Sketch. 681
    You guys sound like that knight that lost all of his arms and legs in Monty Python - I'm sorry - but I think PXS holders need to come to grips with the reality of what this means. It is a terrible outcome, and will cost time and money for big salaries. The IP has a limited lifespan. The US is the market all pharma companies need to get big margins.

    I'm no longer short this co, but am thinking about shorting it again.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.